Two studies presented in March at #ACC19 are the talk of the cardiology community. Both address one question: Can low-risk patients with aortic stenosis benefit from TAVR? UT Southwestern says the data are intriguing, but the excitement is a bit premature. Learn more.
Dharam Kumbhani, M.D. /
Anthony Bavry, M.D.
November 4, 2021
